Project Grant R01CA318829
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $537K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Kenya
Similar Awards
- The National Cancer Institute awarded the University of North Carolina at Chapel Hill $3,112,535 on September 15, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a pilot phase IIA randomized placebo-controlled trial evaluating the safety, adherence, and preliminary efficacy of adjuvant 5-fluorouracil (5FU) as an intravaginal therapy following thermal ablation for cervical precancer treatment in women living with HIV in Kenya. The project addresses high...
- The National Institutes of Health Office of the Director awarded Fred Hutchinson Cancer Center $1,000,792 on September 12, 2025, under the Trans-NIH Research Support program (CFDA 93.310) to conduct a hybrid effectiveness-implementation cluster-randomized controlled trial testing telehealth-supported delivery of HIV pre- and post-exposure prophylaxis (PrEP and PEP) at private pharmacies in Kenya. The study will randomize 20 pharmacies across Kisumu and Homa Bay Counties in Western Kenya...
- The Department of Health and Human Services National Institutes of Health Fogarty International Center awarded $430,734 to Impact Research And Development Organisation on September 13, 2025, under the International Research and Research Training program (CFDA 93.989). The recipient is developing and pilot-testing a multilevel, community-based intervention to reduce pre-exposure prophylaxis (PrEP) stigma and increase PrEP uptake and continuation among adolescent girls and young women ages 15–24...
- The National Cancer Institute awarded Washington State University $560,858 on July 21, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a randomized controlled trial evaluating a remote telehealth intervention combining varenicline and app-based contingency management for rural smokers with alcohol use disorder. The trial will enroll 192 rural smokers seeking smoking cessation treatment and living with an alcohol use disorder. Participants will be...
- Summary The National Cancer Institute (NCI) awarded Fred Hutchinson Cancer Center a Project Grant of $432,098 under the Cancer Biology Research program (CFDA 93.396) on August 4, 2025, for research activities extending through July 31, 2027. This grant supports fundamental cancer biology research investigating HIV persistence and treatment response in Kaposi Sarcoma (KS), with the objective of identifying factors that contribute to differential patient outcomes and informing the design of more...
- The National Institutes of Health Fogarty International Center awarded the Pacific Institute for Research & Evaluation $435,325 on September 15, 2025, under the International Research and Research Training program (CFDA 93.989) to evaluate ASKDOKI, an artificially intelligent mobile health intervention designed to improve sexual and reproductive health outcomes among adolescents aged 15–19 in urban informal settlements in Kenya. ASKDOKI is a WhatsApp chatbot that delivers comprehensive...
- The National Institute on Aging awarded a $1.336 million cooperative agreement to The Aga Khan University–Kenya on September 23, 2025, under the Aging Research program (CFDA 93.866) to develop and validate scalable diagnostic technologies for Alzheimer's disease and related dementias in low- and middle-income countries. The award funds development of an integrated ADRD detection toolkit featuring first-of-its-kind digital speech analysis capturing acoustic features robust to multilingual...
- The National Institute of Mental Health awarded The Regents of the University of California, San Francisco $186,142 on May 1, 2026, under the Mental Health Research Grants program (CFDA 93.242, K01 award K01MH140630) to optimize delivery of biomedical HIV prevention for mobile men in fishing communities along Lake Victoria, Kenya. The project will develop tailored, evidence-based service delivery strategies to improve uptake and adherence to biomedical HIV prevention among fishermen, a key...
- The National Cancer Institute awarded the University of Kentucky Research Foundation $610,625 on August 5, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to implement a pragmatic effectiveness trial of screening, brief intervention, and referral to treatment (SBIRT) for hazardous alcohol use among cancer survivors. The award funds a five-year study randomizing 1,200 head, neck, and esophageal cancer survivors to either a multilevel intervention called...
- The National Cancer Institute awarded the Sloan-Kettering Institute for Cancer Research $177,500 on August 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to adapt and evaluate a community navigator-led tobacco cessation intervention for cancer patients experiencing food insecurity. The project, titled QUITTRACK, addresses the elevated rate of tobacco dependence among food-insecure cancer patients—44 percent of cancer patients who smoke experience food insecurity,...